The Valens Company (TSX: VLNS) (OTCQX: VLNCF) - Investor Dashboard

Follow Company

➔ The Valens Company
TSX: Ticker:	VLNS
OTCQX Ticker:	VLNCF

Market Focus:	Canada
Classification:	Manufacturing & Distribution
Country:	Canada

Employees:	209 as of 11/30/20
Established:	2012
CEO:	Tyler Robson

Summary

Fiscal Year-End:	Nov, 30th
Exchanges:	TSX, OTC
Auditor:	KPMG LLP
Trading Debut:	November 2016
Headquarters:	Toronto, ON

Financials (11/30/20)

Cash on hand:	C$20.3 million
Fixed Investment:	C$53.2 million
Shareholders’ Equity:	C$127.4 million
Revenues – Last Quarter:	C$17.9
Gross Margin :	-33.5%
EPS :	-C$0.13

Capital Structure (02/24/21)

Last Financing:	19.36 million units at C$2.05
Common Shares:	148.7 million
Warrants:	18.6 million
Options:	8.3 million
Diluted Shares:	176.5 million

Company Brief

The Valens Company (Follow Company) is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services across five core technologies, in addition to best-in-class product development, formulation and manufacturing of cannabis consumer packaged goods. The Valens Company’s high-quality products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on next-generation product development and innovation.

Its breakthrough patented emulsification technology, SōRSE™ by Valens, converts cannabis oil into water-soluble emulsions for seamless integration into a variety of product formats, allowing for near-perfect dosing, stability, and taste. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the Company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets.

Featured Video

Through its wholly owned subsidiary Valens Labs Ltd., the Company is setting the standard in cannabis testing and research and development with Canada’s only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific.

Highlights

The largest custom manufacturer of cannabis products in Canada servicing both recreational, medical, and health and wellness markets
Distributing products to Alberta, British Columbia, Manitoba, Ontario and Saskatchewan
Proven full commercialization of SKUs in under 45 business days
Acquisition of Canadian edibles manufacturer, LYF Food Technologies Inc.
First ISO 17025 Accredited Lab

Growth Strategy

Building a diverse IP portfolio that spans across all types of products and services
Increasing output of Cannabis 2.0 and 3.0 products leveraging SōRSE by Valens technology, and gain market share
Expand distribution network, target markets and opportunities that maximize ROI, and export globally with EU GMP certification
Closed the acquisition of LYF Food Technologies, marking entrance into the edibles category

Differentiators

Developing the future of cannabis consumption
A global end-to-end platform providing cannabis extraction and manufacturing for leading LPs, brand houses and CPG companies
Holds five core proprietary cannabis processing technologies at its K2 facility in Kelowna, British Columbia – the most in Canada
Largest third-party vape manufacturer in Canada
Strong R&D and innovation platform
Valens Labs, research and testing facility, Named a “Center of Excellence in Plant Based Science” by ThermoFisher Scientific

Institutional Analyst Coverage

ATB Financial

Stifel GMP

M Partners

Canaccord Genuity

Haywood Securities

Raymond James

Desjardins Securities

M Partners

Raymond James

Curated Stories & News

Visit The Valens Company, Inc.
at www.thevalenscompany.com